about
APP duplication is sufficient to cause early onset Alzheimer's dementia with cerebral amyloid angiopathyThe CALHM1 P86L polymorphism is a genetic modifier of age at onset in Alzheimer's disease: a meta-analysis study.Promoter mutations that increase amyloid precursor-protein expression are associated with Alzheimer disease.APOE and Alzheimer disease: a major gene with semi-dominant inheritanceAlzheimer risk associated with a copy number variation in the complement receptor 1 increasing C3b/C4b binding sites.Both common variations and rare non-synonymous substitutions and small insertion/deletions in CLU are associated with increased Alzheimer risk.Amyloid precursor protein mutation E682K at the alternative β-secretase cleavage β'-site increases Aβ generation.ESCRT-III drives the final stages of CUPS maturation for unconventional protein secretion.Molecular genetics of Alzheimer's disease: an update.Role of progranulin as a biomarker for Alzheimer's disease.Potent amyloidogenicity and pathogenicity of Aβ43.No association of CSF biomarkers with APOEepsilon4, plaque and tangle burden in definite Alzheimer's disease.Alzheimer dementia caused by a novel mutation located in the APP C-terminal intracytosolic fragment.Rescue of progranulin deficiency associated with frontotemporal lobar degeneration by alkalizing reagents and inhibition of vacuolar ATPase.Follow-up study of susceptibility loci for Alzheimer's disease and onset age identified by genome-wide association.SORL1 is genetically associated with increased risk for late-onset Alzheimer disease in the Belgian population.Common variation in GRB-associated Binding Protein 2 (GAB2) and increased risk for Alzheimer dementia.APP and BACE1 miRNA genetic variability has no major role in risk for Alzheimer disease.Serum biomarker for progranulin-associated frontotemporal lobar degeneration.Genetic variability in progranulin contributes to risk for clinically diagnosed Alzheimer disease.Brain-specific tryptophan hydroxylase, TPH2, and 5-HTTLPR are associated with frontal lobe symptoms in Alzheimer's disease.Relative contribution of simple mutations vs. copy number variations in five Parkinson disease genes in the Belgian population.Contribution of TARDBP to Alzheimer's disease genetic etiology.Genetic association of CR1 with Alzheimer's disease: a tentative disease mechanism.Genetic risk and transcriptional variability of amyloid precursor protein in Alzheimer's disease.No association between CALHM1 and risk for Alzheimer dementia in a Belgian population.Alzheimer and Parkinson diagnoses in progranulin null mutation carriers in an extended founder family.The UBQLN1 polymorphism, UBQ-8i, at 9q22 is not associated with Alzheimer's disease with onset before 70 years.Association study of cholesterol-related genes in Alzheimer's disease.DNMBP is genetically associated with Alzheimer dementia in the Belgian population.KChIP3 coupled to Ca oscillations exerts a tonic brake on baseline mucin release in the colonProgranulin genetic variability contributes to amyotrophic lateral sclerosisA Di-Acidic Motif Targets Cytoplasmic Proteins For Unconventional Protein SecretionReplyNew factors for protein transport identified by a genome-wide CRISPRi screen in mammalian cells
P50
Q28259007-CFD68BFD-FAA9-4CD6-A2D7-4FC559479730Q30433658-715AD4F8-39FE-49B7-B029-73C92D63A504Q34658251-7B876A01-E730-4EF6-B437-79D094A9C352Q35181990-129A89D1-96C7-42F4-99A2-74D975A0A904Q35693893-4767D90C-5019-4559-8AC9-1C02711CC6BCQ35811899-BF9C704F-DAEF-4EB6-A2A0-7A3B5E89AC9CQ36038732-11C3828C-C38A-4317-8280-43A6F3788BA3Q36905226-EFE36066-AA16-4880-BD35-27A40BE52FEEQ37209771-2117E1D3-A535-4F89-AA8E-C32014038542Q37730008-603D044D-1120-4AC6-AECB-339AAEF5D525Q39513749-5BAA51E2-DD82-47D2-A81A-8F333C4D7CECQ40201253-39518C47-A564-46DA-A11B-55B0CCD74394Q40242218-2281B490-8CA8-4E6E-BF25-5B717F290084Q41933726-5F5987AD-6F4D-4866-B2F8-6F2AEA8DEF90Q44084931-3F2F6C28-C34A-4C25-A6DC-8AE9641E56F4Q45023837-D10ED449-5566-45EC-8DA7-051B3EC6A9E2Q45086091-7667A2DA-0E6A-4D65-B054-386341564AA8Q46000890-81CB5897-82CD-4908-B38D-7A84F3FA80F9Q46087404-6EA4FF75-AC5A-42E2-8EC3-42791A1B4A45Q46813677-C161E188-CF26-49E6-9114-6DEF04F49819Q46836698-623F65AF-F7A3-4FAC-A57C-D628FC6D55C7Q47910797-D75D6BDE-BD44-430E-9946-A3D8F99ACBF3Q48162352-64C21E19-1971-4181-B536-7920DC8984C5Q48433212-89BA2E81-0AE8-4C3A-8EBA-595A8C675CFEQ48437807-C1228754-2745-4573-9114-C5120AA1B8DDQ48768615-C6DD1D86-8FB3-490F-BE1B-881D635B0910Q51970854-AD838557-CC16-44E9-AF3E-73BF637D5F77Q53272791-EAFBC3DB-B108-4168-A553-0AD827DFE570Q53285747-DEDC3084-5B2D-4F41-BF9B-DAE293F1AE1CQ53392230-BFD7F0C4-63DE-4789-959B-EEE9A71F8B36Q57054611-9A99BBC2-6C82-4838-B01B-8DE175D864A7Q57838448-55811ADC-4579-4C14-801E-9FDB17D69819Q59544970-E3B5EBEE-1CFD-4BE0-BDEA-C2EF3AC64D22Q59544976-CD5FDBDD-DE64-44F2-B343-BB550B5E64FEQ93131996-4D4620D4-2AF6-4388-825C-8174F4EBF139
P50
description
hulumtuese
@sq
researcher
@en
wetenschapper
@nl
հետազոտող
@hy
name
Nathalie Brouwers
@ast
Nathalie Brouwers
@en
Nathalie Brouwers
@es
Nathalie Brouwers
@nl
Nathalie Brouwers
@sl
type
label
Nathalie Brouwers
@ast
Nathalie Brouwers
@en
Nathalie Brouwers
@es
Nathalie Brouwers
@nl
Nathalie Brouwers
@sl
prefLabel
Nathalie Brouwers
@ast
Nathalie Brouwers
@en
Nathalie Brouwers
@es
Nathalie Brouwers
@nl
Nathalie Brouwers
@sl
P1053
L-2089-2014
P106
P1153
9746785200
P21
P31
P3829
P496
0000-0002-9808-9394
P569
2000-01-01T00:00:00Z